FWIA
ALXN

Fort Washington Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Fort Washington Investment Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,098
Closed -$202K – 536
2021
Q2 		$202K Buy
+1,098
New +$188K ﹤0.01% 500
2020
Q1 		– Sell
-2,117
Closed -$229K – 514
2019
Q4 		$229K Hold
2,117
– – ﹤0.01% 472
2019
Q3 		$207K Buy
2,117
+307
+17% +$34.6K ﹤0.01% 486
2019
Q2 		$237K Buy
1,810
+111
+7% +$14.3K ﹤0.01% 480
2019
Q1 		$229K Sell
1,699
-1,417
-45% -$176K ﹤0.01% 484
2018
Q4 		$303K Sell
3,116
-1,272
-29% -$150K ﹤0.01% 450
2018
Q3 		$610K Sell
4,388
-22
-0.5% -$2.76K 0.01% 401
2018
Q2 		$547K Buy
4,410
+1,041
+31% +$122K 0.01% 414
2018
Q1 		$376K Sell
3,369
-380
-10% -$45.4K ﹤0.01% 481
2017
Q4 		$448K Sell
3,749
-172
-4% -$20.9K ﹤0.01% 490
2017
Q3 		$550K Sell
3,921
-672
-15% -$91.3K 0.01% 387
2017
Q2 		$559K Sell
4,593
-2,600
-36% -$303K 0.01% 379
2017
Q1 		$872K Sell
7,193
-162
-2% -$20.9K 0.01% 340
2016
Q4 		$900K Sell
7,355
-2,450
-25% -$300K 0.02% 319
2016
Q3 		$1.2M Hold
9,805
– – 0.02% 248
2016
Q2 		$1.15M Sell
9,805
-2,245
-19% -$319K 0.02% 259
2016
Q1 		$1.68M Sell
12,050
-859
-7% -$126K 0.03% 223
2015
Q4 		$2.46M Sell
12,909
-536
-4% -$93.6K 0.05% 192
2015
Q3 		$2.1M Sell
13,445
-250
-2% -$45.6K 0.04% 211
2015
Q2 		$2.48M Sell
13,695
-3,350
-20% -$578K 0.05% 189
2015
Q1 		$2.95M Sell
17,045
-1,115
-6% -$202K 0.06% 174
2014
Q4 		$3.36M Sell
18,160
-450
-2% -$83.4K 0.07% 159
2014
Q3 		$3.09M Sell
18,610
-16,750
-47% -$2.75M 0.06% 172
2014
Q2 		$5.53M Buy
35,360
+14,000
+66% +$2.21M 0.11% 153
2014
Q1 		$3.25M Sell
21,360
-2,470
-10% -$393K 0.07% 171
2013
Q4 		$3.17M Sell
23,830
-10
-0% -$1.2K 0.07% 185
2013
Q3 		$2.77M Sell
23,840
-1,335
-5% -$146K 0.07% 216
2013
Q2 		$2.32M Buy
+25,175
New +$2.43M 0.05% 248

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Fort Washington Investment Advisors's ALXN Position: Q3 2021 in Review

Fort Washington Investment Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,098 shares — an estimated $202K sold.

Fort Washington Investment Advisors first reported a position in ALXN in Q2 2013 and held it in 28 quarters. The position peaked at $5.53M in Q2 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Fort Washington Investment Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 1,098 Alexion Pharmaceuticals shares in Q3 2021, an estimated $202K.
  • Fort Washington Investment Advisors first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Fort Washington Investment Advisors's Alexion Pharmaceuticals position peaked at $5.53M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Fort Washington Investment Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.